About the 3D Printing Drugs Session
3D Printing Drugs, The Personalized medicine with the revolutionary concept. This groundbreaking technology is transforming the landscape of pharmaceuticals by offering a precise and customizable approach to drug manufacturing. 3D printing allows for the layer-by-layer assembly of pharmaceutical ingredients, enabling the creation of medications with specific dosages, release profiles, and formulations tailored to individual patient needs. This innovation not only streamlines the drug development process but also opens new possibilities for producing complex drug combinations and personalized dosage forms. Embracing 3D printing in drug manufacturing marks a paradigm shift towards patient-centric healthcare, where medications are crafted with precision to maximize efficacy and minimize side effects.
Topics Covered in 3D Printing Drugs
Fused Deposition Modeling Pharmaceuticals
Personalized Dosage Forms
Controlled Release Formulations
Polypill Manufacturing
Pharmaceutical Excipient Development
Regulatory Considerations for 3D Printed Medicines
Related Scientific Sessions at Materials 2027
Why Attend the 3D Printing Drugs Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original 3D Printing Drugs work, reviewed by the scientific committee.
Network Globally
Meet materials researchers, engineers, and academics from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping 3D Printing Drugs research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join Materials 2027 for the 3D Printing Drugs track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
3D Printing Drugs Conference 2027 — FAQs
What is the 3D Printing Drugs track at Materials 2027?
The 3D Printing Drugs track is a dedicated stream within Materials 2027 covering the latest research, methods, and applications in 3D Printing Drugs. It brings together researchers, engineers, and academics for oral presentations, posters, and discussion.
Who should attend the 3D Printing Drugs sessions?
Materials researchers, engineers, educators, doctoral students, and R&D leaders with an interest in 3D Printing Drugs are all welcome — whether presenting or attending.
Can I present my research in the 3D Printing Drugs track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for 3D Printing Drugs sessions?
Yes. Materials 2027 is a hybrid conference — attend the 3D Printing Drugs track in person in Singapore or join live online, with on-demand access afterward.
Join the Materials 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.